维普中文期刊产品整合服务
29篇 您的检索式:作者名="CAROL LIN"
    题名 作者 年代 出处 被引量
1Cancer treatment and survivorship statistics, 2012显示文摘Rebecca Siegel Carol DeSantis Katherine Virgo Kevin Stein Angela Mariotto Tenbroeck Smith Dexter Cooper Ted Gansler Catherine Lerro Stacey Fedewa Chunchieh Lin Corinne Leach Rachel Spillers Cannady Hyunsoon Cho Steve Scoppa Mark Hachey Rebecca Kirch Ahmed 2012CA: A Cancer Journal for Clinicians2012,,4:6
2Portal vein thrombosis in cirrhotic patients-it is always the small pieces that make the big picture显示文摘Portal vein thrombosis(PVT) is a frequent and serious complication in patients with liver cirrhosis(LC). Recently, a new classification of PVT was proposed, although the functional component was not completed included. The status of liver disease(compensated/decompensated) should be added to this classification. Reduced portal flow velocity and the acquired hypercoagulable status associated with LC are the main risk factors for PVT development, although endothelial dysfunction may play an important role that needs to be further evaluated. The European Association for the Study of the Liver and the American Association for the Study of Liver Disease recommend that the anticoagulant treatment should be consider in cirrhotic patients with PVT. Low molecular weight heparin and vitamin K antagonists proved their efficacy and relatively safety in PVT treatment, although in addition to recanalization rates, more complex endpoints such as mortality and decompensation rate should be evaluated. The new oral anticoagulant therapies offers the advantage of oral administration in the absence of laboratory monitoring, however, there are a few reports regarding their use in cirrhotic patients, most of them referring to compensated isolated cases. Transjugular intrahepatic portosystemic shunt could be an alternative if thrombosis progresses despite anticoagulatant therapy and/or when PVT is associated with portal hypertension complications. The aim of this editorial is to discuss the different aspects of pathophysiology, clinical relevance, diagnosis and management of PVT in patients with LC.Irina Girleanu Anca Trifan Carol Stanciu Cǎtǎlin Sfarti 2018World Journal of Gastroenterology2018,24,39:6
3Cancer treatment and survivorship statistics, 2014显示文摘Carol E. DeSantis Chun Chieh Lin Angela B. Mariotto Rebecca L. Siegel Kevin D. Stein Joan L. Kramer Rick Alteri Anthony S. Robbins Ahmedin Jemal 2014CA: A Cancer Journal for Clinicians2014,,4:4
4Aberrantly expressed GFRα-1/RET in patients with lacrimal adenoid cystic carcinoma is associated with high recurrence risk:a retrospective study of 51 LACC cases显示文摘Objective:Because of the poor prognosis of lacrimal adenoid cystic carcinoma(LACC),we aimed to investigate the effects of perineural invasion(PNI)and consequent aberrations in GDNF/GFRα-1/RET protein expression on LACC recurrence.Methods:Clinicopathological data for 51 histologically confirmed patients with LACC enrolled between 2001 and 2017 were retrospectively analyzed.Hematoxylin and eosin staining was applied to assess PNI.Tissue-based immunohistochemistry(IHC)detection of GDNF,GFRα-1,and RET proteins was performed on LACC formalin-fixed,paraffin-embedded specimens.We generated semi-quantitative data of the IHC results and compared them with the clinicopathological data for the 51 patients.Results:Of the 51 patients,19(37.3%)were PNI positive.Recurrence was more common for LACC with than without PNI(73.7%vs.37.5%,P=0.01).GDNF,GFRα-1,and RET proteins were expressed in 62.7%,62.7%,and 54.9%of the 51 patients with LACC,respectively.The expression of all 3 proteins was more common in patients with than without PNI.In agreement with previous findings,PNI-associated GFRα-1 and RET positivity,as detected by IHC,remained significantly associated with recurrence,whereas GDNF expression,as detected by IHC,was not correlated with LACC recurrence.Specifically,patients with concurrent GFRα-1 and RET expression may have a high risk of PNI(89.5%positivity rate)and recurrence(84.2%positivity rate).Conclusions:PNI may contribute to LACC recurrence.The concurrent expression of GFRα-1 and RET proteins,as detected by IHC,may potentially be associated with LACC PNI and recurrence.Lin Liu Liqiong Zhao Jie Zhang Guoxiang Song Carol LShields Ruihua Wei 2021Cancer Biology & Medicine2021,18,1:3
5Cancer treatment and survivorship statistics, 2012显示文摘Rebecca Siegel Carol DeSantis Katherine Virgo Kevin Stein Angela Mariotto Tenbroeck Smith Dexter Cooper Ted Gansler Catherine Lerro Stacey Fedewa Chunchieh Lin Corinne Leach Rachel Spillers Cannady Hyunsoon Cho Steve Scoppa Mark Hachey Rebecca Kirch Ahmed 2012CA: A Cancer Journal for Clinicians2012,,4:2
6p63regulates cell proliferation and cell cycle progression associated genes in stromal cells of giant cell tumor of the bone显示文摘CAROL PO YING LAU MAN SHAN LI LIN HUANG 2013International Journal of Oncology2013,42,2:1
7Comparative effects of exogenous lactase (β-galactosidase) preparations onin vivo lactose digestion显示文摘Meei-Yn Lin PhD Jack A. Dipalma MD Margaret C. Martini PhD Carol J. Gross BS Susan K. Harlander PhD Dennis A. Savaiano PhD 1993Digestive Diseases and Sciences1993,,11:1
8Selected loss of tolerance evidenced by Crohn’s disease–associated immune responses to auto- and microbial antigens显示文摘Carol J. Landers Offer Cohavy Rajeev Misra Huiying Yang Ying–Chao Lin Jonathan Braun Stephan R. Targan 2002Gastroenterology2002,,:1
9Experimental analysis of floc size distributions in a 1-L jar under different hydrodynamics and physicochemical conditions显示文摘Denis Bouyer Carole Coufort Alain Liné Zdravka Do-Quang 2005Journal of Colloid And Interface Science2005,,2:1
10National intel- lectual capital: comparison of the Nordic countries显示文摘Carol Yeh-Yun Lin Leif Edvinsson 2010Journal of Intellectual Capital2010,9,4:1
11Association of antibody responses to microbial antigens and complications of small bowel Crohn’s disease显示文摘William S. Mow Eric A. Vasiliauskas Ying-Chao Lin Phillip R. Fleshner Konstantinos A. Papadakis Kent D. Taylor Carol J. Landers Maria T. Abreu-Martin Jerome I. Rotter Huiying Yang Stephan R. Targan 2004Gastroenterology2004,,:1
12Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn’s disease显示文摘Maria T. Abreu Kent D. Taylor Ying-Chao Lin Tieu Hang Joanne Gaiennie Carol J. Landers Eric A. Vasiliauskas Lori Y. Kam Micha Rojany Konstantinos A. Papadakis Jerome I. Rotter Stephan R. Targan Huiying Yang 2002Gastroenterology2002,,:1
13Biosynthesis of Triacylglycerols Containing Ricinoleate in Castor Microsomes Using 1 - Aeyl - 2 - oleoyl - sn - glycero -3 - phosphochline as the Substrate of Oleoyl - 12 - hy- droxy - lase 显示文摘Jiann - Tsyh Lin Carol L Woodruff Olivier J Lagouche 1998American Oil Chemists Society ( AOCS ) Press1998,33,:1
14Cancer treatment and survivorship statistics,2014显示文摘CAROL E LIN CC ANGELA B 2014CA Cancer J Clin2014,64,4:1
15Toward a Model of Organizational Human Capital Development: Preliminary Evidence from Taiwan显示文摘I-Chieh Hsu Carol Yeh-Yun Lin John J. Lawler Se-Hwa Wu 2007Asia Pacific Business Review2007,,:1
16Analysing global food waste problem: Pinpointing the facts and estimating the energy content显示文摘Melikoglu Mehmet Lin Carol Sze Ki Webb Colin 2013Central European Journal of Engineering2013,3,2:1
17Analysing global food waste problem:pinpointing the facts and estimating the energy content显示文摘Melikoglu Mehmet Lin Carol Sze Ki Webb Colin 2013Central European Journal of Engineering2013,3,2:1
18Clinical characteristics and outcomes associated with nasal intermittent mandatory ventilation in acute pediatric respiratory failure显示文摘AIM To characterize the clinical course and outcomes of nasal intermittent mandatory ventilation(NIMV) use in acute pediatric respiratory failure.METHODS We identified all patients treated with NIMV in the pediatric intensive care unit(PICU) or inpatient general pediatrics between January 2013 and December 2015 at two academic centers.Patients who utilized NIMV with other modes of noninvasive ventilation during the same admission were included.Data included demographics,vital signs on admission and prior to initiation of NIMV,pediatric risk of mortality Ⅲ(PRIsM-Ⅲ) scores,complications,respiratory support characteristics,PICU and hospital length of stays,duration of respiratory support,and complications.Patients who did not require escalation to mechanical ventilation were defined as NIMV responders;those who required escalation to mechanical ventilation(MV) were defined as NIMV nonresponders.NIMV responders were compared to NIMV non-responders.RESULTS Forty-two patients met study criteria.six(14%) failed treatment and required MV.The majority of the patients(74%) had a primary diagnosis of bronchiolitis.The median age of these 42 patients was 4 mo(range 0.5-28.1 mo,IQR 7,P = 0.69).No significant difference was measured in other baseline demographics and vitals on initiation of NIMV;these included age,temperature,respiratory rate,O2 saturation,heart rate,systolic blood pressure,diastolic blood pressure,and PRIsM-Ⅲ scores.The duration of NIMV was shorter in the NIMV nonresponder vs NIMV responder group(6.5 h vs 65 h,P < 0.0005).Otherwise,NIMV failure was not associated with significant differences in PICU length of stay(LOs),hospital LOs,or total duration of respiratory support.No patients had aspiration pneumonia,pneumothorax,or skin breakdown.CONCLUSION Most of our patients responded to NIMV.NIMV failure is not associated with differences in hospital LOs,PICU LOs,or duration of respiratory support.Billy C Wang Theodore Pei Cheryl B Lin Rong Guo David Elashoff James A Lin Carol Pineda 2018World Journal of Critical Care Medicine2018,7,4:1
19Waste printed circuit board recycling techniques and product utilization 显示文摘Pejman Hadi Meng Xu Carol S K Lin 2015Journal of Hazardous Materials2015,,283:1
20Genetic variants in fas signaling pathway genes and risk of gastric cancer显示文摘Paula L. Hyland Shih‐Wen Lin Nan Hu Han Zhang Lemin Wang Hua Su Chaoyu Wang Ti Ding Ze‐Zhong Tang Jin‐Hu Fan You‐Lin Qiao Xiaoqin Xiong William Wheeler Carol Giffen Kai Yu Jeff Yuenger Laurie Burdett Zhaoming Wang Stephen J. Chanock Margaret A. Tucker San 2014Int J Cancer2014,,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费